Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases

Altex

Volumn 30, Issue 4, 2013, Pages 427-444

  Schildknecht, Stefan ^a   Karreman, Christiaan ^a   Pöltl, Dominik ^a   Efrémova, Liudmila ^a   Kullmann, Cornelius ^a   Gutbier, Simon ^a   Krug, Anne ^a   Scholz, Diana ^a   Gerding, Hanne R ^a   Leist, Marcel ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Alpha synuclein; Dopaminergic neurons; LUHMES; Neurotoxicity

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA SYNUCLEIN; ASCORBIC ACID; DEUBIQUITINASE; GREEN FLUORESCENT PROTEIN; PROTEIN VARIANT; RED FLUORESCENT PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL LABELING; CELL MOTILITY; CELL MOTION; CELL ORGANELLE; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; DEGENERATIVE DISEASE; DNA MODIFICATION; FLUORESCENCE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LENTIVIRINAE; MITOCHONDRION; MITOSIS; NERVE FIBER GROWTH; NEURITE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TOXICITY TESTING;

CELL LINE; CLONING, MOLECULAR; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE TRANSFER TECHNIQUES; HUMANS; LENTIVIRUS; NEURODEGENERATIVE DISEASES; NEURONS; TOXICITY TESTS;

EID: 84893041165     PISSN: 1868596X     EISSN: 18688551     Source Type: Journal    
DOI: 10.14573/altex.2013.4.427     Document Type: Article

References (64)

1. Babetto, E., Beirowski, B., Janeckova, L., et al. (2010). Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J Neurosci 30, 13291-13304.
2. Basketter, D. A., Clewell, H., Kimber, I., et al. (2012). A roadmap for the development of alternative (non-animal) methods for systemic toxicity testing - t4 report. ALTEX 29, 3-91.
3. Beirowski, B., Babetto, E., Gilley, J., et al. (2009). Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo. J Neurosci 29, 653-668.
4. Berliocchi, L., Fava, E., Leist, M., et al. (2005). Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis. J Cell Biol 168, 607-618.
5. Biedler, J. L., Helson, L., and Spengler, B. A. (1973). Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33, 2643-2652.
6. Biedler, J. L., Roffler-Tarlov, S., Schachner, M., and Freedman, L. S. (1978). Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38, 3751-3757.
7. Büeler, H. (2009). Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp Neurol 218, 235-246.
8. Coleman, M. P., Conforti, L., Buckmaster, E. A., et al. (1998). An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc Natl Acad Sci U S A 95, 9985-9990.
9. Conforti, L., Fang, G., Beirowski, B., et al. (2007). NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ 14, 116-127.
10. Dong, Z., Ferger, B., Feldon, J., and Büeler, H. (2002). Overexpression of Parkinson's disease-associated alpha-synuclein A53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP. J Neurobiol 53, 1-10.
11. Donnelly, M. L., Luke, G., Mehrotra, A., et al. (2001). Analysis of the aphthovirus 2A/2B polyprotein "cleavage" mechanism indicates not a proteolytic reaction but a novel translational effect: a putative ribosomal "skip." J Gen Virol 82, 1013-1025.
12. Falsig, J., Latta, M., and Leist, M. (2004). Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J Neurochem 88, 181-193.
13. Fountaine, T. M. and Wade-Martins, R. (2007). RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. J Neurosci Res 85, 351-363.
14. Greene, L. A. and Tischler, A. S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73, 2424-2428.
15. Hansson, O., Castilho, R. F., Kaminski Schierle, G. S., et al. (2000). Additive effects of caspase inhibitor and lazaroid on the survival of transplanted rat and human embryonic dopamine neurons. Exp Neurol 164, 102-111.
16. Hatten, M. E. and Liem, R. K. (1981). Astroglial cells provide a template for the positioning of developing cerebellar neurons in vitro. J Cell Biol 90, 622-630.
17. Hatten, M. E. (1985). Neuronal regulation of astroglial morphology and proliferation in vitro. J Cell Biol 100, 384-396.
18. Jang, S. K., Kräusslich, H. G., Nicklin, M. J., et al. (1988). A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62, 2636-2643.
19. Johansson, C. B., Svensson, M., Wallstedt, L., et al. (1999). Neural stem cells in the adult human brain. Exp Cell Res 253, 733-736.
20. Karreman, C. (2002). AiO, combining DNA/protein programs and oligo-management. Bioinformatics 18, 884-885.
21. Kaul, S., Anantharam, V., Kanthasamy, A., and Kanthasamy, A. G. (2005). Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death. Brain Res Mol Brain Res 139, 137-152.
22. Knott, A. B., Perkins, G., Schwarzenbacher, R., and Bossy-Wetzel, E. (2008). Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9, 505-518.
23. Kremer, M., Henn, A., Kolb, C., et al. (2010). Reduced immunoproteasome formation and accumulation of immunoproteasomal precursors in the brains of lymphocytic choriomeningitis virus-infected mice. J Immunol 185, 5549-5560.
24. Leander Johansen, J., Dagø, L., Tornøe, J., et al. (2005). A new versatile and compact lentiviral vector. Mol Biotechnol 29, 47-56.
25. Lee, G., Chambers, S. M., Tomishima, M. J., and Studer, L. (2010). Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 5, 688-701.
26. Lee, M., Hyun, D., Halliwell, B., and Jenner, P. (2001). Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem 76, 998-1009.
27. Lehmensiek, V., Tan, E. M., Schwarz, J., and Storch, A. (2002). Expression of mutant alpha-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro. Neuroreport 13, 1279-1283.
28. Leist, M., Kadereit, S., and Schildknecht, S. (2008). Food for thought ... on the real success of 3R approaches. ALTEX 25, 17-32.
29. Leist, M., Efremova, L., and Karreman C. (2010). Food for thought ... considerations and guidelines for basic test method descriptions in toxicology. ALTEX 27, 309-317.
30. Leist, M., Lidbury, B. A., Yang, C., et al. (2012). Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods. ALTEX 29, 373-388.
31. Lopes, F. M., Schröder, R., da Frota, M. L. Jr., et al. (2010). Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337, 85-94.
32. Lotharius, J., Barg, S., Wiekop, P., et al. (2002). Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 277, 38884-38894.
33. Lotharius, J., Falsig, J., van Beek, J., et al. (2005). Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25, 6329-6342.
34. Lunn, E. R., Perry, V. H., Brown, M. C., et al. (1989). Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur J Neurosci 1, 27-33.
35. Mack, T. G., Reiner, M., Beirowski, B., et al. (2001). Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 4, 1199-1206.
36. Maltsev, A. S., Chen, J., Levine, R. L., and Bax., A. (2013). Site-specific interaction between α-synuclein and membranes probed by NMR-observed methionine oxidation rates. J Am Chem Soc 135, 2943-2946.
37. Manning-Bog, A. B., McCormack, A. L., Purisai, M. G., et al. (2003). Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J Neurosci 23, 3095-3099.
38. Matentzoglu, K. and Scheffner, M. (2009). Ubiquitin-fusion protein system: a powerful tool for ectopic protein expression in mammalian cells. Biotechniques 46, 21-28.
39. Nieto, M., Gil-Bea, F. J., Dalfó, E., et al. (2006). Increased sensitivity to MPTP in human alpha-synuclein A30P transgenic mice. Neurobiol Aging 27, 848-856.
40. Påhlman, S., Ruusala, A. I., Abrahamsson, L., et al. (1984). Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14, 135-144.
41. Paul, G., Christophersen, N. S., Raymon, H., et al. (2007). Tyrosine hydroxylase expression is unstable in human immortalized mesencephalic cell line-studies in vitro and after intracerebral grafting in vivo. Mol Cell Neurosci 34, 390-399.
42. Pöltl, D., Schildknecht, S., Karreman, C., and Leist, M. (2012). Uncoupling of ATP-depletion and cell death in human dopaminergic neurons. Neurotoxicology 33, 769-779.
43. Rathke-Hartlieb, S., Kahle, P. J., Neumann, M., et al. (2001). Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. J Neurochem 77, 1181-1184.
44. Schildknecht, S., Pöltl, D., Nagel, D. M., et al. (2009). Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol Appl Pharmacol 241, 23-35.
45. Schildknecht, S., Pape, R., Müller, N., et al. (2011). Neuroprotection by minocycline caused by direct and specific scavenging of peroxynitrite. J Biol Chem 286, 4991-5002.
46. Schildknecht, S., Gerding, H. R., Karreman, C., et al. (2013). Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies. J Neurochem 125, 491-511.
47. Schlüter, O. M., Fornai, F., Alessandrí, M. G., et al. (2003). Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced parkinsonism in mice. Neuroscience 118, 985-1002.
48. Scholz, D., Pöltl, D., Genewsky, A., et al. (2011). Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem 119, 957-971.
49. Scholz, D., Chernyshova, Y., and Leist, M. (2013). Control of Aβ release from human neurons by differentiation status and RET signaling. Neurobiol Aging 34, 184-199.
50. Seaton, T. A., Cooper, J. M., and Schapira, A. H. (1997). Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 777, 110-118.
51. Sherer, T. B., Betarbet, R., Testa, C. M., et al. (2003). Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci 23, 10756-10764.
52. Singleton, A. B., Farrer, M., Johnson, J., et al. (2003). Alpha-Synuclein locus triplication causes Parkinson's disease. Science 302, 841.
53. Specht, C. G. and Schoepfer, R. (2001). Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci 2, 11.
54. Stefanis, L. (2012). α-Synuclein in Parkinson's disease. Cold Spring Harb Perspect Med 2, a009399.
55. Stiegler, N. V., Krug, A. K., Matt, F., and Leist, M. (2011). Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol Sci 121, 73-87.
56. van Thriel, C., Westerink, R. H., Beste, C., et al. (2012). Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts. Neurotoxicology 33, 911-924.
57. Vattem, K. M. and Wek, R. C. (2004). Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A 101, 11269-11274.
58. Vergo, S., Johansen, J. L., Leist, M., and Lotharius, J. (2007). Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels. Brain Res 1185, 18-32.
59. Wilbrey, A. L., Haley, J. E., Wishart, T. M., et al. (2008). VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S). Mol Cell Neurosci 38, 325-340.
60. Wu, F., Poon, W. S., Lu, G., et al. (2009). Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells. Brain Res 1292, 173-179.
61. Yu, W. H., Matsuoka, Y., Sziráki, I., et al. (2008). Increased dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in transgenic mice expressing mutant A53T alpha-synuclein. Neurochem Res 33, 902-911.
62. Zhu, M., Li, W., and Lu, C. (2012). Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines. PLoS One 7, e36377.
63. Zimmer, B., Schildknecht, S., Kuegler, P. B., et al. (2011a). Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. Toxicol Sci 121, 357-367.
64. Zimmer, B., Kuegler, P. B., Baudis, B., et al. (2011b). Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death Differ 18, 383-395.